Indaptus Therapeutics implements 1-for-28 reverse stock split effective June 26, 2025

Indaptus Therapeutics, Inc.

Reverse stock split at ratio of 1-for-28 effective after market close on June 26, 2025.
Trading on split-adjusted basis begins June 27, 2025; new CUSIP 45339J 204.
Purpose is to regain Nasdaq continued listing compliance and attract institutional investors.
Outstanding shares reduced from ~16 million to ~572 thousand; no change in authorized shares.
Proportionate adjustments made to options, warrants; fractional shares paid in cash.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.